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Abstract
Personality can be thought of as a set of characteristics that influence people’s thoughts, feelings,
and behaviour across a variety of settings. Variation in personality is predictive of many outcomes
in life, including mental health. Here we report on a meta-analysis of genome-wide association
(GWA) data for personality in ten discovery samples (17 375 adults) and five in-silico replication
samples (3 294 adults). All participants were of European ancestry. Personality scores for
Neuroticism, Extraversion, Openness to Experience, Agreeableness, and Conscientiousness were
based on the NEO Five-Factor Inventory. Genotype data were available of ~2.4M Single
Nucleotide Polymorphisms (SNPs; directly typed and imputed using HAPMAP data). In the
discovery samples, classical association analyses were performed under an additive model
followed by meta-analysis using the weighted inverse variance method. Results showed genome-
wide significance for Openness to Experience near the RASA1 gene on 5q14.3 (rs1477268 and
rs2032794, P = 2.8 × 10−8 and 3.1 × 10−8) and for Conscientiousness in the brain-expressed
KATNAL2 gene on 18q21.1 (rs2576037, P = 4.9 × 10−8). We further conducted a gene-based test
that confirmed the association of KATNAL2 to Conscientiousness. In-silico replication did not,
however, show significant associations of the top SNPs with Openness and Conscientiousness,
although the direction of effect of the KATNAL2 SNP on Conscientiousness was consistent in all
replication samples. Larger scale GWA studies and alternative approaches are required for
confirmation of KATNAL2 as a novel gene affecting Conscientiousness.
Keywords
Personality; Five-Factor Model; Genome-wide association; Meta-analysis; Genetic variants
The structure of human personality has traditionally been accounted for by a relatively small
set of traits. Over the last century, scientific consensus has converged on a taxonomic model
of personality traits based on five higher-order dimensions of Neuroticism, Extraversion,
Openness to Experience, Agreeableness and Conscientiousness, known as the Five-Factor
Model (FFM).1 These five dimensions are largely independent and provide a broad
description of personality. Neuroticism is commonly defined as emotional instability; it
involves the experience of negative emotions such as anxiety, depression, hostility, and the
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vulnerability to stress. Extraversion is characterized by positive emotions, gregariousness,
and the tendency to be active, seek out stimulation and enjoy the company of others.
Openness to Experience involves active imagination, aesthetic attentiveness, variety
preference and intellectual curiosity. Agreeableness can be defined as the tendency to be
cooperative and compassionate rather than suspicious and antagonistic towards others.
Lastly, the dimension of Conscientiousness reflects self-discipline, carefulness,
thoroughness, organization, deliberation and achievement.
Personality traits predict a host of social, behavioral and health outcomes, such as job
performance, longevity, and many psychiatric disorders, including substance abuse and
dependency, mood disorders such as major depressive disorder (MDD), anxiety disorders,
and personality disorders.2-7 For example, Neuroticism reflects a liability trait for MDD and
other mood and anxiety disorders and also explains part of the comorbidity among these
disorders.3,6,8,9 MDD is also predicted by low Conscientiousness.10,11 With regard to
substance (ab)use, tobacco smokers score high on Neuroticism and low on
Conscientiousness.12,13 A similar but more extreme pattern is seen for cocaine and heroin
users; in contrast, marijuana users score high on Openness to Experience and low on
Agreeableness and Conscientiousness.13 The FFM dimensions further predict tendencies
toward different types of personality disorder, with high scores on Neuroticism and low
scores on Agreeableness predicting many of the personality disorders and with low or high
scores on Extraversion predicting different disorders.2,14 Personality is also predictive of
beneficial outcomes. High Conscientiousness predicts better performance in the
workplace10,13,15 and high Extraversion larger participation in regular leisure time
exercise.16,17
Twin, adoption and family studies have convincingly shown that each of the FFM
personality dimensions is heritable, with heritability estimates ranging between 33% and
65%.18-21 Lower-order facets that underlie personality dimensions are genetically
correlated 22, confirming the notion that the higher-order personality dimensions are to a
large extent genetically homogenous. Importantly, genetic influences on personality partly
overlap with the genetic factors that influence psychiatric disorders.3,6,10,20 Thus, gene
finding efforts for the major personality dimensions may yield important insights into the
genetic etiology of psychiatric disease.
Gene-finding studies for personality, including genome-wide linkage and association
studies, have largely focused on Neuroticism, as measured by the Eysenck Personality
Questionnaire or as part of the FFM.23-31 Few studies have also included other traits such as
Extraversion.27,31 The study by Terracciano et al.31 is to date the only genome-wide
association study conducted for all five FFM personality dimensions. This study was
performed in an isolated sample of 3 972 Sardinians, analyzing ~362k single nucleotide
polymorphisms (SNPs). Although none of the observed signals reached genome-wide
significance (lowest p-value 9.4*10-7), several of the top signals were found in genes that
are thought to affect behavioral traits and mental disorders through differential brain
functioning (for example SNAP25 for Neuroticism, CDH13 for Extraversion and CLOCK
for Agreeableness).
The aim of the current meta-analytic study was to identify novel genetic variants associated
with the FFM personality dimensions by combining genome-wide association (GWA) study
results from 10 studies, including 17 375 individuals of European ancestry from Europe, the
United States and Australia. In-silico replication of the genome-wide significant SNPs was
sought in five additional samples consisting of 3 294 individuals.
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Materials and Methods
Discovery samples
The samples included in the discovery stage of this study are described below. Approval by
local institutional review boards was obtained in all studies and written informed consent
was given.
SardiNIA - Italy—The SardiNIA study includes 6 148 related individuals from four towns
in the Ogliastra province of Sardinia, Italy.21 These individuals represent 62% of the
population in these towns. Valid NEO-PI-R1 personality data were available for 5 669
individuals, of which 3 972 were genotyped (56.7% women). The mean age of all
participants was 42.8 years (SD=17). The mean age of the men was 43.0 years (SD=18), and
of the women 42.4 years (SD=17). The sample has been described in more detail by
Terracciano and coauthors.31
NTR/NESDA - The Netherlands—The NTR/NESDA study consists of unrelated
individuals from Dutch twin families registered at the Netherlands Twin Register (NTR)32
and participants from the Netherlands Study of Depression and Anxiety (NESDA).33
Individuals were selected to be genotyped as part of the Genetic Association Information
Network (GAIN) initiative34, of which 1 836 served as controls (mainly from NTR) and 1
862 as cases (mainly from NESDA) in a genome-wide association study for major
depressive disorder.35,36 Controls were selected for absence of an MDD diagnosis and/or a
low genetic liability for MDD. In this study, 3 540 individuals (65.6% women) were
included with valid NEO personality and GWA data. The mean age of participants was 44.1
years (SD=13). Men were slightly older (M=46.6 years; SD=13) than women (M=42.8
years; SD=13). Personality data from NTR participants were collected in 200437 and from
NESDA participants between 2004-2007.33
ERF – The Netherlands—The Erasmus Rucphen Family (ERF) study is a family-based
study including over 3 000 individuals from an isolated population in the South-West region
of the Netherlands.38 There were 2 400 individuals for whom both NEO personality and
GWA data were available. The mean age of all participants was 49.3 years (SD=14.9) and
women constituted 55.8% of the total sample (M=47.4; SD=15, versus in men M=48.2,
SD=14).
SAGE – United States of America—The Study of Addiction: Genetics and
Environment (SAGE) is part of the Gene Environment Association Studies initiative
(GENEVA) funded by the National Human Genome Research Institute. The sample consists
of DSM-IV alcohol dependent cases and non-dependent controls.39 The original SAGE
sample included 4 121 unrelated individuals. Of these, 2 223 subjects had data available
from the NEO-FFI. We removed 476 subjects due to non-European ancestry, 8 individuals
were removed due to missing genotypes, and 139 were removed because their genotyping
consent did not include the use of their personality data. This resulted in a final sample size
of 1 600. Of these 1 600, 60.1% were women. The mean age of all participants was 39.6
(SD=9), of the men 40.4 (SD=10) and of the women 39.0 (SD=9).
HBCS - Finland—The Helsinki Birth Cohort Study (HBCS) is composed of 8 760
individuals born between the years 1934-1944 in one of the two main maternity hospitals in
Helsinki, Finland. Between 2001 and 2003, a randomly selected sample of 928 males and 1
075 females participated in a clinical follow-up study with a focus on cardiovascular,
metabolic and reproductive health, cognitive function and depressive symptoms. In 2004,
various psychological phenotypes were assessed, including the NEO personality dimensions.
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There were 1 443 subjects with both valid phenotype and genotype data (59.8% women).
The mean age of the subjects was 63.4 (SD=3). The mean age of the men was 63.3 (SD=3)
and of the women was 63.5 (SD=3). Detailed information on the selection of the HBCS
participants and on the study design can be found elsewhere.40-42
NAG/IRPG study - Australia—Phenotype data from this study were collected as part of
the Nicotine Addiction Genetics study (NAG), for which families were targeted based on
heavy smoking index cases identified in previous interviews and questionnaires.43,44
Personality items, from the NEO-FFI, were included in a questionnaire mailed to all
participants. Genotype data came from the Interactive Research Project Grants (IRPG).
Valid personality and genotype data were available for 1 349 individuals aged 21-85 years
(M=45.4; SD=13.1). Of these, 56% were women (M=45.4, SD=13) and 44% men (M=45.3,
SD=13).
QIMR study - Australia—Data from Australian adolescents were collected in twin family
studies conducted at the Queensland Institute of Medical Research. Participants were mainly
recruited through primary and secondary schools in Queensland for studies of melanocytic
naevi (moles).45 NEO personality data (NEO-PI-R or NEO-FFI) were collected as part of
the cognition study (in-person testing, 1996-ongoing)46, as well as a health and wellbeing
study (a mail/phone study 2002-2003)46, and a study of borderline personality disorder
(online/paper survey 2004-2006).47 For the current study, personality and genotypic data
were available for 1 090 individuals (616 females), of whom 254 were monozygotic twin
pairs (for whom average phenotypic data were analyzed). Participants ranged in age from 16
to 27 (M=19.4; SD=3). The mean ages in men and women were very similar (M=19.2,
SD=3 in men versus M=19.4, SD=3 in women).
LBC1936 – United Kingdom—The Lothian Birth Cohort study consists of a cohort of 1
091 individuals born in 1936 (LBC1936). Most subjects lived independently in the Lothian
region (Edinburgh city and surrounding area) of Scotland. The majority of subjects took part
in the Scottish Mental Surveys of 1947, and were assessed again on cognition and medical
traits at roughly 70 years of age.48 A fuller description about participant recruitment and
testing can be found elsewhere.48,49 There were 888 subjects (447 female) who successfully
filled in the NEO-FFI and survived the DNA and genotyping quality control procedures.
The mean age of these 888 subjects was 69.6 (SD=1). The mean ages of the men and women
were the same.
BLSA – United States of America—The Baltimore Longitudinal Study of Aging
(BLSA) is an ongoing multidisciplinary study of community-dwelling volunteers.
Personality traits were assessed from 1989 to 2008, and multiple assessments were available
for most participants. Although personality traits are generally stable over time50,51, to
provide more robust estimates, we used the average across all available assessments. For the
current study, we examined data from 848 subjects of European descent that were
successfully genotyped and completed the NEO-PI-R questionnaire at least once. In this
sample, mean age was 68.5 (SD = 17) with 46% of women. The mean age of the men was
60.8 years (SD=16), and of the women 55.9 years (SD=17).
EGPUT - Estonia—The Estonian cohort comes from the population-based biobank of the
Estonian Genome Project of University of Tartu (EGPUT). The project is conducted
according to the Estonian Gene Research Act and all participants have signed the broad
informed consent (www.geenivaramu.ee).52 In total 38 000 individuals aged 18 years or
older participated in this cohort (33% male, 67% female). The population distributions of the
cohort reflect those of the Estonian population (83% Estonians, 14% Russians, 3% other).
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Subjects were randomly recruited by the general practitioners (GP) and physicians in the
hospitals.53 A Computer Assisted Personal interview (CAPI) was conducted during 1-2
hours at doctors’ offices. Data on demographics, genealogy, educational and occupational
history, lifestyle and anthropometric and physiological data were assessed. For the current
study, GWA was performed on 600 randomly selected subjects with both Illumina
HumanCNV370 genotype (array according to Illumina protocol (www.illumina.com) in
Estonian Biocenter Genotyping Core Facility) and the NEO-PI-3 questionnaire data
available54. In this sample the age range was 18-87 (mean 45.7 (SD 16) years). The sample
consisted of 250 males (mean age 45.5 (SD=16) years) and 350 females (mean age 45.7
(SD=16) years).
Replication samples
The samples for in-silico replication are described below. In total, the sample size was 3 294
subjects.
NTR+ - The Netherlands—Within the Netherlands Twin Register, several genotyping
projects (additional to the first genome-wide genotyping study that was part of the GAIN-
MDD study) have been undertaken whose data were combined in the current study to form
the replication set. All individuals came from the NTR-Biobank study55. In total, 1 920
individuals with valid NEO-FFI and GWA data were available for replication. The mean age
of participants was 46.9 years (SD=15) and 67% was female. This sample included 127 MZ
twin pairs (254 twins) with phenotype data in both twins. Those twin pairs were treated as
one case in the analysis by averaging their phenotypic scores, resulting in a sample with 1
793 subjects for analysis. For 1 475 subjects, GWA data were available on one SNP chip;
for 318 subjects, GWA data were assessed on two chips. For the majority of the 1 475
subjects genotyped on one chip (N=1 286; 87%), genotyping was part of the NTR2
genotyping study using the Illumina Human660W-Quad chip. These subjects were unrelated
and unselected for any phenotype. The remaining subjects were genotyped as part of the
GenomEUtwin study (N=137 subjects; Illumina 370k chip), an Attention Deficit
Hyperactivity Disorder study (N=34 subjects; Affymetrix 6.0) and the MDD2000 study
(N=18 MDD cases; Illumina 907K chip). Quality control of genotype data and subsequent
imputation using IMPUTE software was conducted on separate sets, and on the full set of all
genotyped individuals within the NTR. For the purposes of this replication study, after
imputation we selected the SNPs from the discovery set that showed genome-wide
significance, checked their quality and subsequently analyzed the SNPs.
GERMANY—In this German cohort, 2 420 healthy control participants were randomly
selected from the general population of Munich, Germany, and contacted by mail. We
included 476 individuals (56% females) with GWA data (Illumina HumanHap300 chip) in
this study. Several screenings were conducted before the volunteers were enrolled in the
study. First, subjects who responded were initially screened by phone for the absence of
neuropsychiatric disorders. Second, detailed medical and psychiatric histories were assessed
for the participants and their first-degree relatives by using a semi-structured interview56.
Third, if no exclusion criteria were fulfilled, they were invited to a comprehensive interview
including the SCID to validate the absence of any lifetime psychotic disorder57.
Additionally, the Family History Assessment Module was conducted to exclude psychotic
disorders among their first-degree relatives. A neurological examination was also conducted
to exclude subjects with current central nervous system impairment. If participants were
older than 60 years, the Mini Mental Status Test was performed to exclude subjects with
possible cognitive impairment58. Only participants with German descent (all 4 grandparents
German) were included. Furthermore, a large battery of personality questionnaires e.g. on
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aggression, impulsivity or neuroticism (NEO-PI-R) was obtained as well as data on life
events and traumatic events. The mean age of the sample was 46 years (SD=15).
EGPUT2 - Estonia—In the Estonian cohort, additional data of 380 individuals with valid
NEO-FFI and GWA data have become available for replication. For a more detailed
description of this cohort, see the description above for EGPUT. The mean age of
participants was 38.9 years (SD=15). Almost half of the sample (49.5%) was female.
Cilento– Italy—The Cilento study is a population-based study that includes 2 137
individuals from three isolated populations of South Italy. Of these individuals, 859 were
genotyped on the 370K SNP map from Illumina. Imputation of 2.5M HapMap SNPs was
obtained using MACH software. Genome-wide significant SNPs were selected, checked and
analyzed. Data available from the NEO-PI-R questionnaire were available for 343
genotyped subjects representing the final sample. Of this sample, 65.6% were women. The
mean age of all participants was 58.9 (SD=19), of the men 59.5 (SD=18.8) and of the
women 58.7 (SD= 19).
ERF2- The Netherlands—The ERF2 sample consisted of 302 additionally genotyped
individuals with NEO personality data within the family-based ERF study (see the
description above for more information on this study). The mean age of these individuals
was 50.1 years (SD=14). Women constituted 50.3% of the sample.
Personality assessment
Personality scores for the five factors Neuroticism, Extraversion, Openness to Experience,
Agreeableness, and Conscientiousness were based on the 60 items of the NEO Five-Factor
Inventory (NEO-FFI) (12 items per factor).1 Items were answered on a 5-point Likert-type
scale ranging from strongly disagree (0) to strongly agree (4). In the SardiNIA, BSLA,
Germany and Cilento studies, these items were taken from the 240-item NEO-PI-R 1. In the
QIMR study, the 60 items were taken from the 240-item NEO-PI-R for part of the sample;
the remaining subjects filled in the 60-item NEO-FFI.1 In the NTR, NESDA, ERF, SAGE,
HBCS, NAG/IRPG and LBC1936 studies, personality was assessed using the 60-item NEO-
FFI. In the Estonian study samples, the 60 NEO-FFI items 59 were taken from the NEO-
PI-3.54,60
In each study, summed scores were computed for all five personality dimensions (after
reversing negatively keyed items). If more than three items were missing per dimension, the
summed score for that dimension was not computed. If three or less items were missing,
missing data were imputed by taking the individual’s average score for the valid items of
that dimension. The mean scores of the five personality dimensions in each study are
provided in Table 1.
Genotyping and imputation
DNA was extracted from blood samples in all participating studies. A detailed overview of
SNP genotyping, including the platforms used and subsequent quality control, is given in
Table 2. The studies used Illumina platforms, except for SardiNIA and NTR/NESDA, which
used Affymetrix and Perlegen platforms, respectively. Genotype data were checked in each
study independently, using slightly different inclusion criteria. Among the basic checks that
were performed were checks for European ancestry, Mendelian errors, gender
inconsistencies and high genome-wide homozygosity. Checks for relatedness were carried
out in those samples that aimed to use unrelated individuals. Genotype data were further
checked based on Hardy-Weinberg Equilibrium (HWE), minor allele frequencies (MAF),
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SNP call rate (% of subjects with missing genotypes per SNP) and sample call rate (% of
missing SNPs per subject).
In order to compare results at the SNP level, we imputed ~2.5M common SNPs included in
HapMap, using the HapMap phase II CEU data as the reference sample. Most studies used
NCBI build 36 (UCSC hg18), although in the NTR/NESDA study build 35 (UCSC hg17)
was used. Imputation was carried out using IMPUTE for the NTR/NESDA, SAGE and EGP
samples (consisting of unrelated individuals).61 For all other samples, genotype data were
imputed using MACH software. For those studies that contained related individuals, a
maximum likelihood approach was used that takes advantage of the relatedness among
individuals.62 Throughout this paper, the location of SNPs reported is taken from the build
36 (release 22) HapMap data.
Statistical analyses
GWA analysis in each discovery sample—Genome-wide association analyses were
conducted in each study independently using linear regression (under an additive model) and
including sex and age as covariates. For those studies that used IMPUTE software to impute
missing genotype data, association analyses were conducted in SNPtest, taking the
uncertainty of the imputed genotypes into account.61 For the studies that used MACH to
impute their data, either MACH QTL or Merlin was used for association analyses. For the
three studies with related individuals (SardiNIA, ERF and QIMR), association analyses were
performed in Merlin using a variance components approach, which takes into account the
relatedness among individuals in these samples.62
Meta-analysis of GWA results across discovery samples—A meta-analysis of the
results was conducted using the weighted inverse variance method in METAL (http://
www.sph.umich.edu/csg/abecasis/metal/index.html)63, which computes a pooled effect
estimate (ln(beta)), its standard error and its p-value by weighing the effect estimates of the
individual samples by the inverse of it’s variance and by taking into account the direction of
effect. Poorly imputed SNPs (r-squared or proper_info < 0.30) and SNPs with low minor
allele frequency (MAF<0.01) were excluded, resulting in a final dataset of ~2.4M SNPs. We
corrected for any population stratification effects by applying genomic control in each
sample prior to meta-analysis. The genomic control inflation factors (λ) for the five
personality dimensions for all participating studies ranged between 0.99 and 1.12
(Supplementary Table 1). After applying a genomic control correction to the results from the
individual studies, the λ’s for the meta-analyzed results were 1.02, 1.01, 1.03, 1.00 and 1.02,
respectively, for Neuroticism, Extraversion, Openness to Experience, Agreeableness and
Conscientiousness. The corresponding Quantile-Quantile plots are provided in
Supplementary Figure 1. To consider a SNP result genome-wide significant, we used the
threshold of P < 5 × 10−8 per trait as proposed for populations of European descent.64
Gene-based tests—In addition to the meta-analytic association testing per SNP, we also
evaluated the significance of all genes across the genome. We followed the procedure
proposed by Liu et al. and incorporated in the program VEGAS65, which is suitable for
meta-analysis results because it does not require raw genotype data but instead uses the p-
values of SNPs as input. Gene-based p-values were obtained by using a maximum of 107
simulations to correctly account for the linkage disequilibrium (LD) structure among SNPs
within a gene. We included SNPs located up to 20kb down- or upstream of a gene. A gene
was considered genome-wide significant if a P < 2.5 × 10−6 (0.05 / 20 000) was obtained.
Replication analyses—Replication of the SNPs that turned out genome-wide significant
was performed in five independent samples. In each sample, an additive test was conducted,
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with sex and age as covariates. SNPs in each sample were checked for minor allele
frequency, Hardy-Weinberg equilibrium and if imputed, for imputation quality. The
evidence for replication was summarized across samples by conducting a weighted inverse
variance meta-analysis. A P < 0.05 was taken as significant evidence of replication.
Results
Two SNPs for Openness to Experience on chromosome 5q14.3 and one SNP for
Conscientiousness on chromosome 18q21.1 passed the genome-wide significance level of P
< 5 × 10−8 in the discovery stage (Table 3). The genome-wide meta-analyzed association
results for the five personality dimensions are given in Supplementary Figure 2. Top SNPs
for Neuroticism, Extraversion and Agreeableness (Supplementary Tables 2 to 6) did not
reach genome-wide significance (lowest P value > 10−8).
The two genome-wide significant SNPs for Openness to Experience (rs1477268, rs2032794,
r-squared among SNPs ranges between 0.92 and 1 across studies) are located on
chromosome 5q14.3 in an intergenic region 135kb downstream from the RASA1 gene
(lowest P = 2.8 × 10−8, with an explained variance of 0.22%) (Figure 1a). The gene-based P
value for RASA1 was 0.02. RASA1 codes for a GTPase activating protein involved in
intracellular signaling and cellular proliferation and differentiation. The gene is highly
expressed in the bone marrow and bone, and modestly in the brain.66 Further, Figure 2a
shows that the effect for rs1477268 is in the same direction for nine of the ten studies.
Heterogeneity in results across studies was not significant (χ2 = 9.15, df = 9, P = 0.42). The
SNP was genotyped in seven of the studies and imputed with high quality in the SardiNIA,
NTRNESDA and ERF studies (r-squared or proper_info > 0.97). The MAFs were very
similar across studies and ranged between 0.15 and 0.24. Furthermore, genotype and allele
proportions of rs1477268 are in HWE in all studies (P > 0.01). The association of these two
SNPs with Openness to Experience could not, however, be replicated (combined P across
the replication samples 0.53 and 0.55 respectively for rs1477268 and rs2032794, combined
P across discovery and replication samples 1.84 × 10−6 and 1.70 × 10−6).
The genome-wide significant SNP for Conscientiousness (rs2576037) is located in an intron
of the KATNAL2 gene on chromosome 18q21.1 (P = 4.9 × 10−8, explained variance
0.21%.). The second-most significant SNP for Conscientiousness (rs7233515) is a non-
synonymous SNP in the same gene (lowest P = 7.9 × 10−8, the r-squared with rs2576037
ranges between 0.92 and 1 across studies, Figure 1b). Variation in this SNP leads to a N88S
amino acid change, suggesting a biologically relevant variation. In eight studies the direction
of the effect for rs2576037 was the same (Figure 2b). In spite of this, there was nominal
significant heterogeneity in the regression coefficients across studies (χ2 = 17.98, df = 9, P =
0.04). To test which study caused the observed heterogeneity, we reran the meta-analysis
multiple times, by each time excluding one of the individual studies. Two studies seemed to
account for the heterogeneity. Excluding the Finnish HBCS study (with the largest effect),
heterogeneity was no longer significant (χ2 = 11.30, df = 8, P = 0.19) and the pooled p-value
became 4.3 × 10−6. When excluding the NAG/IRPG study (a small opposite effect),
heterogeneity was also no longer observed (χ2 = 11.20, df = 8, P = 0.19) and the pooled p-
value became 2.2 × 10−9. The SNP was genotyped in seven of the studies and imputed with
high quality in the SardiNIA, NTRNESDA and ERF studies (r-squared or proper_info >
0.98). The MAFs were very similar across studies and ranged between 0.37 and 0.46 and
distributions were in HWE in all studies (P > 0.01).
KATNAL2 encodes a protein similar to the A subunit of the p60 katanin protein and is
widely expressed in the central nervous system.66 Katanin p60 acts to sever microtubules in
the axons of neurons and is thought to play a role in neuronal migration, axonal growth and
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dendritic pruning.67-69 Thus, the KATNAL2 gene may play a role in neurodevelopment.
Several other SNPs located in the nearby PIAS2, HDHD2 and IER3IP1 genes that are in
relatively high LD (r-squared > 0.5) with the top SNP showed suggestive evidence for
association (P < 1 × 10−5) (Figure 1b and Supplementary Table 6). The PIAS2 gene is
involved in the regulation of transcription factors involved in the mitogen-activated protein
kinase signaling pathway. Less is known about the biological function of the HDHD2 and
IER3IP1 genes, but all three genes are moderately expressed in the brain.66
KATNAL2 was significant in gene-based tests as well (Table 3 and Supplementary Table
7). The cluster of small TCEB3 genes, located within the KATNAL2 gene (Figure 1b), was
also significant, but the other genes in the region were not genome-wide significant. This
suggests that the causal variant may be located in or very near the KATNAL2 gene rather
than in any of the surrounding genes. The association of rs2576037 was again not significant
in the replication stage (combined P across replication samples = 0.36), although the
direction of effect was consistent with the effect found in the discovery stage
(Supplementary Table 8). The combined P value across all discovery and replication
samples for rs2576037 was 1.02 × 10−7.
We also investigated the significance of SNPs that have previously been reported in the first
GWA study for the FFM personality traits (Supplementary Table 9) and in the two GWA
studies for Neuroticism (Supplementary Table 10).23,24,30 None of the SNPs reported in
these studies were significant (p>0.001).
Discussion
This study suggests evidence for two new loci associated with two dimensions of
personality: an intergenic region 135kb downstream from RASA1 on 5q14.3 for Openness
to Experience and the KATNAL2 gene region on 18q21.1 for Conscientiousness. However,
these loci were not unequivocally replicated. The KATNAL2 gene was also significant in
the gene-based test. However, in the replication samples the effect did not reach a level of
significance, although there was a consistency of direction of effects Thus, KATNAL2
might present a novel gene for personality. It should be noted however that even if the signal
represents a true finding, the effect size is small. No genome-wide significant results were
found for Neuroticism, Extraversion and Agreeableness.
Power analyses showed that the genome-wide significant variants could not have been
detected in any of the individual studies at the genome-wide significant level (power to
detect these effects at α=5 × 10−8 in sample sizes smaller than 4 000 is less than 1%), but the
power to detect these effects in the current meta-analytic study with a sample size of 17 375
is 77% for the top SNP for Openness to Experience and 72% for the top SNP of
Conscientiousness. Additional power analyses showed that with a power of 80%, the meta-
analysis could detect much smaller effect sizes than any of the individual studies (0.23%
explained variance versus 1% to 6.5% explained variance for sample size of individual
studies between 600 and 3 972; explained variances correspond to standardized betas of 0.05
versus 0.1 to 0.25).
The findings of the current study show that large-scale collaborative studies with combined
sample sizes on the order of thousands or ten thousands still have difficulties in identifying
common genetic variants that influence complex phenotypes such as personality traits. It
could be that the effects of many SNPs are even smaller than the 0.2% that we were able to
detect in this study at a genome-wide significance level. Larger GWA studies may reveal
these variants, as has been already successfully demonstrated for human height in a large
meta-analytic GWA study of over 180 000 individuals, in which at least 180 loci were
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identified together explaining about 10% of the variation in height.70 In addition, a recent
paper using a novel technique to estimate the genetic variance explained by all SNPs,
without focusing on genome-wide significance of individual SNPs, showed that common
SNP variation explained about half of the heritability of human height.71 These papers are
consistent with the notion that common SNP variation is important in explaining complex
highly polygenic traits. It also suggests that the meta-analytic GWA study that we present
here was only able to detect the top few SNPs with the largest effect sizes related to
personality.
Many other explanations to explain the heritability of complex traits have been put
forward.72 One of these is that other variants that are currently not captured with the
genome-wide SNP platforms (including copy number and rare variants) play a role in
explaining variation in personality. Next-generation sequencing may reveal more genetic
variants that account for the heritability of complex traits including personality.
Nevertheless, identification of genetic variants, even if effect sizes are small, remains an
important goal, because these variants can be critical entry points to increased understanding
of the biological processes underlying personality as well as psychiatric disorders and other
personality-related health, social and behavioral outcomes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Regional association plots of the two SNPs genome-wide significant in the discovery set for
Openness to Experience and Conscientiousness
a. Chromosome 5 locus for Openness to Experience
b. Chromosome 18 locus for Conscientiousness
Foot note: Physical positions of SNPs and genes are based on build 36 (hg18). The top SNP
is shown in blue. SNPs that have an r-squared between 0.8-1 with the top SNP are shown in
violet, SNPs with an r-squared between 0.5-0.8 in red, SNPs with an r-squared between
0.2-0.5 in orange, and < 0.2 in yellow.
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Figure 2.
Association of the two SNPs genome-wide significant in the discovery set with Openness to
Experience and Conscientiousness
a. Association of rs1477268 with Openness to Experience
b. Association of rs2576037 with Conscientiousness
Foot note: Effects are reported for the minor allele (see Supplementary Tables 4 and 6).
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Table 1
Mean scores of the five personality dimensions in the 10 studies participating in the GWASNEO Consortium,
stratified across sex
Total
sample Men Women
Neuroticism Mean SD Mean SD Mean SD
1. SardiNIA 22.6 7.3 20.2 6.5 24.4 7.3
2. NTR/NESDA 21.3 9.6 19.6 9.7 22.2 9.4
3. ERF 19.2 7.9 17.6 7.6 20.5 7.9
4. SAGE 18.9 8.6 18.5 8.8 19.2 8.5
5. HBCS 16.9 9.4 14.5 8.7 18.6 9.5
6. NAG/IRPG 20.0 8.2 18.9 7.8 20.8 8.3
7. QIMR 26.5 6.6 27.0 6.5 26.3 6.7
8. LBC1936 17.1 7.7 15.7 7.5 18.5 7.6
9. BLSA 16.0 6.2 15.3 5.8 16.9 6.6
10. EGPUT 21.9 7.8 20.4 7.4 23.0 8.0
Extraversion Mean SD Mean SD Mean SD
1. SardiNIA 27.9 5.2 27.9 4.8 28.0 5.5
2. NTR/NESDA 26.6 7.4 26.1 7.5 26.8 7.4
3. ERF 28.0 6.5 28.3 6.6 27.7 6.5
4. SAGE 29.3 6.7 28.1 6.6 30.1 6.6
5. HBCS 26.2 7.7 25.9 7.7 26.4 7.6
6. NAG/IRPG 27.7 6.2 27.6 6.1 27.7 6.2
7. QIMR 28.3 5.9 27.4 5.7 29.1 5.8
8. LBC1936 27.0 5.9 26.5 6.1 27.4 5.7
9. BLSA 27.6 5.5 27.2 5.4 28.2 5.6
10. EGPUT 26.2 8.2 25.4 7.8 26.7 8.4
Openness to Experience Mean SD Mean SD Mean SD
1. SardiNIA 26.9 5.6 26.0 5.4 27.6 5.7
2. NTR/NESDA 24.9 5.6 24.7 5.8 25.0 5.5
3. ERF 21.4 5.6 21.2 5.4 21.6 5.8
4. SAGE 27.1 6.1 27.3 6.4 27.0 5.9
5. HBCS 27.5 7.4 26.1 7.5 28.4 7.2
6. NAG/IRPG 26.0 6.2 24.9 6.2 26.9 6.0
7. QIMR 22.5 5.8 21.6 5.9 23.2 5.7
8. LBC1936 26.0 5.8 25.2 5.7 26.8 5.8
9. BLSA 28.4 5.7 27.3 5.6 29.6 5.7
10. EGPUT 22.7 6.7 20.9 6.1 24.0 6.8
Agreeableness Mean SD Mean SD Mean SD
1. SardiNIA 30.7 4.8 29.4 4.6 31.7 4.7
2. NTR/NESDA 32.3 5.2 30.7 5.2 33.2 4.9
3. ERF 31.7 5.6 30.1 5.3 33.1 5.4
4. SAGE 33.2 6.2 30.2 6.3 35.2 5.2
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Total
sample Men Women
5. HBCS 33.0 6.3 31.4 6.3 34.1 6.1
6. NAG/IRPG 32.1 5.5 30.0 5.4 33.7 5.1
7. QIMR 28.3 5.1 27.8 4.7 28.8 5.4
8. LBC1936 33.4 5.3 31.8 5.2 35.0 4.9
9. BLSA 32.4 4.3 31.2 4.0 33.8 4.2
10. EGPUT 27.9 5.5 26.5 5.5 28.9 5.3
Conscientiousness Mean SD Mean SD Mean SD
1. SardiNIA 32.5 5.7 32.6 5.6 32.5 5.8
2. NTR/NESDA 29.3 6.8 29.6 6.9 29.2 6.8
3. ERF 34.5 5.8 34.7 5.7 34.3 5.8
4. SAGE 33.5 6.4 32.3 6.3 34.3 6.4
5. HBCS 34.4 7.6 34.4 7.6 34.5 7.5
6. NAG/IRPG 33.3 6.1 32.3 5.2 34.1 6.0
7. QIMR 29.2 5.6 28.7 5.1 29.6 5.9
8. LBC1936 34.7 6.0 34.4 6.1 34.9 5.9
9. BLSA 32.2 5.6 31.8 5.4 32.7 5.9
10. EGPUT 33.9 6.5 33.2 6.4 34.4 6.5
SD = Standard Deviation
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Table 2
Genotyping information in the 10 studies participating in the GWASNEO Consortium
Study sample Genotyping platform Quality control of genotyped SNPs prior to imputation
HWE p-
value
SNP call
rate
Sample call
rate
MAF
1. SardiNIA Affymetrix 10K (N=3 329) and 500K (N=1,412)
(overlap N=436)
1×10−6 0.90 0.95 0.05
2. NTR/NESDA Perlegen 600K - 0.95 0.75 0.01
3. ERF Illumina 6k, 317k and 370k, Affymetrix 250k Chip
specific
Chip
specific
Chip specific Chip
specific
4. SAGE Illumina 1M 1×10−4 0.95 0.98 0.005
5. HBCS Illumina 610K 1×10−6 0.95 - 0.01
6. NAG/IRPG 274,604 common SNPs from Illumina 610K/ 370K/
317K
1×10−6 0.95 0.95 0.01
7. QIMR Illumina 610K 1×10−5 0.90 0.90 0.01
8. LBC1936 Illumina 61 OK 1×10−3 0.98 0.95 0.01
9. BLSA Illumina 5 5 OK 1×10−4 0.99 0.97 0.01
10. EGPUT Illumina 370K 1×10−6 0.98 0.95 0.01
- = no threshold applied
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Table 3
Genome-wide significant associations with Openness to Experience and Conscientiousness in the discovery
samples of the GWASNEO Consortium for the Five-Factor Model of personality, and associations in the
replication samples
Pooled results
in discovery samples
Pooled results
in replication samples
Pooled results
in all samples
SNP Chr Closest gene Location Allelesa Effect s.e. P value Effect s.e. P value P value
Openness to Experience
rs1477268 5q14.3 RASA1 Intergenic CT 0.48 0.09 2.8 × 10−08 −0.12 0.19 0.53 1.84 × 10−6
rs2032794 5q14.3 RASA1 Intergenic CT 0.48 0.09 3.1 × 10−08 −0.11 0.19 0.55 1.70 × 10−6
Conscientiousness
rs2576037 18q21.1 KATNAL2 Intron TC −0.41 0.07 4.9 × 10−08 −0.13 0.14 0.36 1.02 × 10−7
SNP=Single Nucleotide Polymorphism, Chr=Chromosome, Effect = unstandardized regression coefficient, s.e.= standard error, MAF=Minor
Allele Frequency, HWE=Hardy-Weinberg equilibrium
a
First allele is the minor allele, for which the effect is reported.
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